NSCLC,4,CAMP,CAMP,0,28 days,Bitran JD~ et al: CANCER TREAT REP 1976; 60:1225-1230.,5,28 days,8b62 NSCLC,3,CAP,CAP,0,28 days,Eagan RT~ et al: CANCER TREAT REP 1979; 63:1589-1591.,6,28 days,4490 NSCLC,2,CBDCA+VP-16,CBDCA+VP16,0,28 days,Klastersky JP: J CLIN ONCOL 1990; 8:1556-1562.,15,28 days,ea9f NSCLC,2,CDDP + VP-16,CDDP+VP16,0,21-28 days,Longeval E~ et al: CANCER 1982; 50:2751-2756.,17,21-28 days,c973 NSCLC,3,FED,FED,0,3 weeks,Sridhar KS~ et al: SEMIN IN SURG ONCOL 1993; 9:114-119.,10,3 weeks,3478 NSCLC,3,MVP,MVP,0,21 days,Bonomi PD~ et al: J CLIN ONCOL 1989; 7:1602-1613.,13,21 days,19df NSCLC,1,NVB[Navelbine(R)]-15,NVB-15,0,None,LeChevalier T~ et al: J CLIN ONCOL 1994; 12:360-367.,18,None,c62e NSCLC,1,NVB[Navelbine(R)]-30,NVB-30,0,None,LeChevalier T~ et al: J CLIN ONCOL 1994; 12:360-367.,18,None,cec7 NSCLC,2,NVB-15+CDDP,NVB15+CDDP,0,None,LeChevalier T~ et al: J CLIN ONCOL 1994; 12:360-367.,18,None,fdaf NSCLC,2,NVB-30+CDDP,NVB30+CDDP,0,None,LeChevalier T~ et al: J CLIN ONCOL 1994; 12:360-367.,18,None,135a NSCLC,2,PVP-16,PVP-16,0,21-28 days,Klastersky J: SEMIN IN ONCOL 1986; 13(Suppl 3):104-114.,15,21-28 days,a174 NSCLC,3,VIP(ICE)-2,VIP(ICE)-2,0,28 days,Perez EA~ et al: PROC ASCO 1992; 11:314.,16,28 days,db63